Is Goldman Sachs Stock Still a Buy After Earnings?
Goldman Sachs stock is struggling for direction Tuesday even after the financial giant beat expectations for its third quarter. Here's what you need to know.
Goldman Sachs (GS) stock jumped more than 3% at Tuesday's open after the investment banking giant disclosed its third-quarter results, but was last seen in negative territory.
In the quarter ended September 30, Goldman's net revenue increased 7.5% year-over-year to $12.7 billion, led by a 16.2% surge in revenue in its Asset & Wealth Management segment to $3.8 billion. The company also said earnings per share (EPS) were up 53.6% from the year-ago period to $8.40.
"Our performance demonstrates the strength of our world-class franchise in an improving operating environment," said Goldman Sachs CEO David Solomon in a statement. "We continue to lean into our strengths – exceptional talent, execution capabilities and risk management expertise – allowing us to effectively serve our clients against a complex backdrop and deliver for shareholders."
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The results crushed analysts expectations. Wall Street was anticipating revenue of $11.8 billion and earnings of $6.89 per share, according to Yahoo Finance.
Goldman also proudly noted that its Assets Under Supervision (AUS) reached a record $3.1 trillion, an increase of 15.8% over the year-ago period.
Is Goldman Sachs stock a buy, sell or hold?
Goldman Sachs has been one of the best Dow Jones stocks on the price charts this year, up 38.1% on a total return basis (price change plus dividends) through the October 14 close. Unsurprisingly, Wall Street is very bullish on the financial stock. According to S&P Global Market Intelligence, the consensus recommendation among analysts it tracks is a Buy.
However, analysts' price targets have struggled to keep up with the stock's outperformance in 2024. Currently, the average price target on GS is $526.63, which is a discount to where the blue chip stock is trading at the time of this writing. Price-target hikes could come down the pike if shares keep climbing.
"Goldman Sachs is poised for a 2024 recovery in investment banking from the market trough in 2023, which would benefit GS as the global leader," wrote CFRA Research analyst Kenneth Leon in an October 4 note. "A revamped strategy to focus on core businesses and drive more durable, recurring fee revenue is underway in Asset & Wealth Management."
Leon went on to note that his firm sees Goldman Sachs benefitting from an upturn in transaction fee activities and private equity funds exiting investments through initial public offerings.
Related content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Affordability Crisis: Florida Votes to Increase Property Tax Break
State Tax Property taxes have skyrocketed nearly 60% within the last five years in Florida, and its constituents are finally doing something about it.
By Gabriella Cruz-Martínez Published
-
Average Net Worth by Age: How Do You Measure Up?
Financial advisors discuss the secrets to growing your net worth over time.
By Adam Shell Published
-
Three Charitable Giving Strategies for High-Net-Worth Individuals
If you have $1 million or more saved for retirement, these charitable giving strategies can help you give efficiently and save on taxes.
By Joe F. Schmitz Jr., CFP®, ChFC® Published
-
The Wealth-Building Powers of Health Savings Accounts (HSAs)
Health savings accounts could be the most underutilized wealth-building tool out there. Here’s who should use them and how to maximize their benefits.
By Eric Roberge, Certified Financial Planner (CFP) and Investment Adviser Published
-
Seven Ways to Be an Absolute Jerk as a Lawyer
Here's what law students need to know about damaging their relationships with other lawyers and judges and running up the bill for clients.
By H. Dennis Beaver, Esq. Published
-
Stock Market Today: Stocks Are Positively Mixed to Open December
Technology led the way Monday as two of the three main equity indexes closed higher.
By David Dittman Published
-
The Best Retail Stocks to Buy This Holiday Season
E-commerce is a growing trend, but most folks still prefer to shop in stores. That makes these dominant retail stocks worth a closer look.
By Louis Navellier Published
-
One Good Way to Withdraw Retirement Assets (and a Bad One)
Don't withdraw retirement assets haphazardly. Managing distributions intentionally can lower your taxes, conserve your wealth and reduce Medicare premiums.
By Justin Haywood, CFP® Published
-
What Is Capital Gains Tax Deferral?
Spoiler alert: It's the secret weapon of savvy real estate investors. Here's how it works and details about the tools you need to do it.
By Daniel Goodwin Published
-
Don't Leave Your Heirs an IRA Tax Bomb
Your traditional IRA has served you well, but when your heirs inherit it, watch out. Consider some of these strategies to minimize their tax burdens.
By Kelsey M. Simasko, Esq. Published